Supplementary Methods:
Whole blood collected from male Fitch ferrets was collected and incubated with TLR agonist compounds including Imiquimod (TLR7), the TLR7/8 agonist CL057 (Invivogen), and the synthetic TLR4 agonist GLA. Following incubation, RNA was collected from both stimulated and saline controls using an RNA whole blood extraction kit (Qiagen). Levels of RNA for TLR7, TLR8, IL-1β, and IL-8 were determined by real time PCR using established protocols 1 . Expression level changes were graphed as fold change in RNA levels relative to saline stimulated blood samples.
Intracellular cytokine staining
In order to quantify vaccine specific T cell responses, splenocytes were isolated from five mice per group following vaccination. Red blood cells were lysed using Red Blood Cell Lysis Buffer (eBioscience) and resuspended in cRPMI 1640(10% FBS, 1% Penicillin/Streptomycin; 0.1% 2-Mercaptoethanol). Cells were plated at 10 7 cells/well in 96-well plates and were stimulated for 2 hours with media or rHA (10 µg/mL) at 37˚C. 
Supplementary Tables
Supplementary Table T1 . Zeta potentials of representative liposome and emulsion formulations containing 3M-052.
Formulation
Estimated 3M-052 Zeta Potential (mV) Concentration (mg/ml)* PEGylated Liposome --37.1 ± 4.8
PEGylated Liposome 0.04 -27.1 ± 1.1
Oil-in-water emulsion --4.2 ± 0.6
Oil-in-water emulsion 0.04 -8.6 ± 1.0 *3M-052 content was not measured for these batches but was estimated to be 0.04 mg/ml based on subsequent batches manufactured using the same process. 
Supplementary

Supplementary Figures
Supplementary Figure S1 . Liposomal and oil-in-water emulsion formulations of 3M-052 demonstrate long-term particle size stability.
(a) Particle diameter and (b) size polydispersity index of representative lipid-based formulations of 3M-052 at 5°C for 6 months. Error bars represent standard deviation of three separate particle size assays from a single formulation batch at each timepoint. 3M-052 content was not
